-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Phio Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference September 13th-15th
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market
-
21,796 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

